Sputnik-V: The Russian COVID-19 Vaccine Russia has suffered over four million cases of COVID-19, making it the fourth worst-affected country. Joining other countries around the world, Russia threw itself into the global vaccination race and developed a homegrown COVID-19 vaccine. Read more ...
The vaccine, named Sputnik V, was developed by the Gamaleya Research Institute of Epidemiology and Microbiology, based in Moscow and supported by the Russian Ministry of Health. It uses an adenovirus vector to deliver the gene for the SARS-CoV-2 spike protein, a similar approach to that being...
NEW DELHI - India Saturday received the first shipment of Russian COVID-19 vaccine -- Sputnik V, officials said. "Sputnik-V vaccine arrives in Hyderabad from Russia! Will add to India's arsenal to fight the pandemic. This third option will augment our vaccine capacity and accelerate our vacc...
The scheduled delivery to Argentina this week of doses of Russia's Sputnik V vaccine has been delayed indefinitely, a government source in Buenos Aires told AFP Tuesday. An Aerolineas Argentinas flight was scheduled to depart to Russia last Sunday to bring back a third batch of the 19.4 millio...
Calculation was based on the analysis of data of volunteers who received both the first and second doses of the Sputnik V vaccine or placebo at the third and final control point of 78 confirmed cases in accordance with the Phase III clinical trials protocol, the government said. The a...
Iran's ambassador to Russia said Saturday that Tehran expects to receive the first batch of Moscow's Sputnik V coronavirus vaccine by February 4, state news agency IRNA reported.
The European Commission has shed doubt on the Russian vaccine, Sputnik V. European Commission president Ursula von der Leyen on Wednesday (17 February) posed questions on its use. "We still wonder why Russia is offering theoretically millions of millions of doses while not sufficiently progressing...
Russia’s Sputnik V vaccine has been getting a lot of traction globally — over 30 countries and territories now have given emergency approval to use the vaccine. “I think the bottom line is that countries are putting aside ideology, and looking for cost-effective, and effective vaccines.”...
The 'Sputnik V' vaccine was granted regulatory approval by Moscow in August, making it the first in the world to be given the green light despite concerns among health officials that the vaccine had not yet undergone large-scale Phase III trials, or had its results peer-reviewed. Russia rej...
Interim data from the phase three trial of the Covid-19 vaccine from Russia, Gam-COVID-Vac (Sputnik V), suggests a two-dose regimen of the vaccine offers 91.6% efficacy. The preliminary findings, published in The Lancet, are based on analysis of data from nearly 20,000 ...